FSD Pharma, Inc. (HUGE) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Rapid Dose Therapeutics Corp.

Avicanna, Inc.

Microbix Biosystems, Inc.

Ceapro, Inc.

Cardiol Therapeutics, Inc.

Oncolytics Biotech, Inc.

Medicenna Therapeutics Corp.

Sernova Corp.

BriaCell Therapeutics Corp.

FSD Pharma, Inc.

Cognetivity Neurosciences Ltd.

Why is FSD Pharma, Inc. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is FSD Pharma, Inc. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

FSD Pharma, Inc.

-66.2%

0.02

4835.50%

S&P/TSX 60

23.72%

1.43

14.72%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

6.08%

EBIT to Interest (avg)

-31.55

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.87

Sales to Capital Employed (avg)

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

3.40%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.11

EV to EBIT

-0.31

EV to EBITDA

-0.32

EV to Capital Employed

1.20

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

-386.03%

ROE (Latest)

-197.98%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

Bullish

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

No Trend

Mildly Bullish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company

NET PROFIT(HY)

Higher at CAD -10.17 MM

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

INVENTORY TURNOVER RATIO(HY)

Highest at 13.7 times

EPS(Q)

Highest at CAD -1.93

-11What is not working for the Company

INTEREST(HY)

At CAD 0.47 MM has Grown at 1,740.21%

NET PROFIT(Q)

Fallen at -27.87%

Here's what is working for FSD Pharma, Inc.

EPS

Highest at CAD -1.93

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CAD)

Inventory Turnover Ratio

Highest at 13.7 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Raw Material Cost

Fallen by 0% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for FSD Pharma, Inc.

Interest

At CAD 0.47 MM has Grown at 1,740.21%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CAD MM)

Net Profit

Fallen at -27.87%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CAD MM)